BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29212899)

  • 1. Novel Mutation in
    Tucker NR; McLellan MA; Hu D; Ye J; Parsons VA; Mills RW; Clauss S; Dolmatova E; Shea MA; Milan DJ; Scott NS; Lindsay M; Lubitz SA; Domian IJ; Stone JR; Lin H; Ellinor PT
    Circ Cardiovasc Genet; 2017 Dec; 10(6):. PubMed ID: 29212899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy.
    Brodehl A; Ferrier RA; Hamilton SJ; Greenway SC; Brundler MA; Yu W; Gibson WT; McKinnon ML; McGillivray B; Alvarez N; Giuffre M; Schwartzentruber J; ; Gerull B
    Hum Mutat; 2016 Mar; 37(3):269-79. PubMed ID: 26666891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pathogenic variants in filamin C identified in pediatric restrictive cardiomyopathy.
    Schubert J; Tariq M; Geddes G; Kindel S; Miller EM; Ware SM
    Hum Mutat; 2018 Dec; 39(12):2083-2096. PubMed ID: 30260051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium.
    Bermúdez-Jiménez FJ; Carriel V; Santos-Mateo JJ; Fernández A; García-Hernández S; Ramos KA; Piqueras-Flores J; Cabrera-Romero E; Barriales-Villa R; de la Higuera Romero L; Alcalá López JE; Gimeno Blanes JR; Sánchez-Porras D; Campos F; Alaminos M; Oyonarte-Ramírez JM; Álvarez M; Tercedor L; Brodehl A; Jiménez-Jáimez J
    Rev Esp Cardiol (Engl Ed); 2023 May; 76(5):301-311. PubMed ID: 35952944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel filamin C (FLNC) variant causes a severe form of familial mixed hypertrophic-restrictive cardiomyopathy.
    Gaudreault N; Ruel LJ; Henry C; Schleit J; Lagüe P; Champagne J; Sénéchal M; Sarrazin JF; Philippon F; Bossé Y; Steinberg C
    Am J Med Genet A; 2023 Jun; 191(6):1508-1517. PubMed ID: 36864778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare clinical phenotype of filaminopathy presenting as restrictive cardiomyopathy and myopathy in childhood.
    Muravyev A; Vershinina T; Tesner P; Sjoberg G; Fomicheva Y; Čajbiková NN; Kozyreva A; Zhuk S; Mamaeva E; Tarnovskaya S; Jornholt J; Sokolnikova P; Pervunina T; Vasichkina E; Sejersen T; Kostareva A
    Orphanet J Rare Dis; 2022 Sep; 17(1):358. PubMed ID: 36104822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLNC and MYLK2 Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy.
    Qin X; Li P; Qu HQ; Liu Y; Xia Y; Chen S; Yang Y; Huang S; Wen P; Zhou X; Li X; Wang Y; Tian L; Hakonarson H; Wu Y; Zhuang J
    Int Heart J; 2021 Jan; 62(1):127-134. PubMed ID: 33455984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel combination of
    Kumar V; Kumar P; Chauhan L; Dwivedi A; Ramamurthy HR
    J Genet; 2022; 101():. PubMed ID: 36560844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo mutations in FLNC leading to early-onset restrictive cardiomyopathy and congenital myopathy.
    Kiselev A; Vaz R; Knyazeva A; Khudiakov A; Tarnovskaya S; Liu J; Sergushichev A; Kazakov S; Frishman D; Smolina N; Pervunina T; Jorholt J; Sjoberg G; Vershinina T; Rudenko D; Arner A; Sejersen T; Lindstrand A; Kostareva A
    Hum Mutat; 2018 Sep; 39(9):1161-1172. PubMed ID: 29858533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations.
    Ader F; De Groote P; Réant P; Rooryck-Thambo C; Dupin-Deguine D; Rambaud C; Khraiche D; Perret C; Pruny JF; Mathieu-Dramard M; Gérard M; Troadec Y; Gouya L; Jeunemaitre X; Van Maldergem L; Hagège A; Villard E; Charron P; Richard P
    Clin Genet; 2019 Oct; 96(4):317-329. PubMed ID: 31245841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
    Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy.
    Valdés-Mas R; Gutiérrez-Fernández A; Gómez J; Coto E; Astudillo A; Puente DA; Reguero JR; Álvarez V; Morís C; León D; Martín M; Puente XS; López-Otín C
    Nat Commun; 2014 Oct; 5():5326. PubMed ID: 25351925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.
    Wu W; Lu CX; Wang YN; Liu F; Chen W; Liu YT; Han YC; Cao J; Zhang SY; Zhang X
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26163040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.
    Ortiz-Genga MF; Cuenca S; Dal Ferro M; Zorio E; Salgado-Aranda R; Climent V; Padrón-Barthe L; Duro-Aguado I; Jiménez-Jáimez J; Hidalgo-Olivares VM; García-Campo E; Lanzillo C; Suárez-Mier MP; Yonath H; Marcos-Alonso S; Ochoa JP; Santomé JL; García-Giustiniani D; Rodríguez-Garrido JL; Domínguez F; Merlo M; Palomino J; Peña ML; Trujillo JP; Martín-Vila A; Stolfo D; Molina P; Lara-Pezzi E; Calvo-Iglesias FE; Nof E; Calò L; Barriales-Villa R; Gimeno-Blanes JR; Arad M; García-Pavía P; Monserrat L
    J Am Coll Cardiol; 2016 Dec; 68(22):2440-2451. PubMed ID: 27908349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titin mutation in familial restrictive cardiomyopathy.
    Peled Y; Gramlich M; Yoskovitz G; Feinberg MS; Afek A; Polak-Charcon S; Pras E; Sela BA; Konen E; Weissbrod O; Geiger D; Gordon PM; Thierfelder L; Freimark D; Gerull B; Arad M
    Int J Cardiol; 2014 Jan; 171(1):24-30. PubMed ID: 24315344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell-Cell Adhesion Structures.
    Begay RL; Graw SL; Sinagra G; Asimaki A; Rowland TJ; Slavov DB; Gowan K; Jones KL; Brun F; Merlo M; Miani D; Sweet M; Devaraj K; Wartchow EP; Gigli M; Puggia I; Salcedo EE; Garrity DM; Ambardekar AV; Buttrick P; Reece TB; Bristow MR; Saffitz JE; Mestroni L; Taylor MRG
    JACC Clin Electrophysiol; 2018 Apr; 4(4):504-514. PubMed ID: 30067491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filamin C in cardiomyopathy: from physiological roles to DNA variants.
    Song S; Shi A; Lian H; Hu S; Nie Y
    Heart Fail Rev; 2022 Jul; 27(4):1373-1385. PubMed ID: 34535832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter by Ma et al Regarding Article, "Novel Mutation in
    Ma Y; Huang J; Zhou Z
    Circ Genom Precis Med; 2018 Apr; 11(4):e002117. PubMed ID: 29650767
    [No Abstract]   [Full Text] [Related]  

  • 19. Response by Ma et al to Letter Regarding Article, "Novel Mutation in
    Tucker NR; Ellinor PT
    Circ Genom Precis Med; 2018 Apr; 11(4):e002140. PubMed ID: 29650770
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias.
    Ohiri JC; Dellefave-Castillo L; Tomar G; Wilsbacher L; Choudhury L; Barefield DY; Fullenkamp D; Gacita AM; Monroe TO; Pesce L; Blancard M; Vaught L; George AL; Demonbreun AR; Puckelwartz MJ; McNally EM
    J Am Heart Assoc; 2024 May; 13(10):e030467. PubMed ID: 38761081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.